Procyon Ridge Capital writes first checks into life sciences startups founded by students, faculty, and recent graduates of Washington University, Brown University, Ben Gurion University, and the Technion.
We write checks of $5K–$250K, often before there's a product, a deck, or even a registered company. Capital is just the entry point. What we actually do is work alongside founders through the earliest, hardest part of building a life sciences company — when the questions outnumber the answers.
We help you think through FDA pathways from day one, so your science and your strategy develop together rather than colliding later.
Our relationships span researchers, clinicians, KOLs, and operators across all four institutions. We make introductions that move things forward.
University spin-outs face unique licensing challenges. We've navigated these processes and help founders work through tech transfer agreements without losing momentum.
We actively help founders identify and pursue NIH SBIR/STTR grants, DOD programs, and foundation funding to extend runway without giving up more equity.
The first few hires define a company's trajectory. We help founders think through who to bring on first, how to structure equity, and how to attract scientific advisors.
When you're ready to raise a seed or Series A, we open doors to the right investors and help you sharpen the narrative before you're in the room.
If you're a student, faculty, or recent graduate at WashU, Brown, BGU, or the Technion working on something in life sciences — we want to hear from you. We respond to every pitch.
